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THE DEFICIENCIES OF THE EUROPEAN UNION’S
REGULATORY SYSTEM GOVERNING THE
CLASSIFICATION OF ENDOCRINE
DISRUPTING CHEMICALS
ELISSA SANFORD*
INTRODUCTION
The European Union has issued a new regulatory scheme that
proposes to identify and regulate endocrine disrupting chemicals with in-
creased specificity.1 However, its methodology and plan to carry out the
new regulations are lacking in preventative approaches and will likely
result in under-inclusion of the chemicals, to the detriment of the public
health.2 The United States has a similar program that is distinct in its
approach to regulation of these toxins.3 Endocrine disrupting chemicals
are subjected to a heightened concern based on new and recent data that
shows undesirable trends, including the increase of hormone-related
cancers and an increase in fertility issues.4 Other prevalent health issues
* JD Candidate, William & Mary Law School, 2020. Old Dominion University, 2016. The
author would like to thank the dedicated staff of the William & Mary Environmental Law
and Policy Review for their diligent work on publishing this Note.
1 Commission Regulation (EU) 2018/605 of Apr. 19, 2018, Amending Annex II to Regu-
lation (EC) No. 1107/2009 by Setting out Scientific Criteria for the Determination of
Endocrine Disrupting Properties, 2018 O.J. (L 101), https://eur-lex.europa.eu/legal-con
tent/EN/TXT/PDF/?uri=CELEX:32018R0605&from=EN [https://perma.cc/BJ27-TY37]
[hereinafter Commission Regulation 2018/605].
2 Press Release, Endocrine Society, EU Criteria Fall Short of Protecting Public from En-
docrine Disrupting Chemicals (June 7, 2018), https://www.endocrine.org/news-room/2018
/eu-criteria-fall-short-of-protecting-public-from-endocrine-disrupting-chemicals
[https://perma.cc/7UXS-6Y2N].
3 Endocrine Disruptor Screening Program (EDSP) in the 21st Century, EPA, https://www
.epa.gov/endocrine-disruption/endocrine-disruptor-screening-program-edsp-21st-century
[https://perma.cc/3AP3-25CN] (last updated June 24, 2019) [hereinafter EDSP in the 21st
Century]; Endocrine Disruptor Screening Program (EDSP) Overview, EPA, https://www
.epa.gov/endocrine-disruption/endocrine-disruptor-screening-program-edsp-overview
[https://perma.cc/HTQ9-H64J] (last updated Feb. 22, 2017) [hereinafter EDSP Overview].
4 See Gwynne Lyons, Hazard Versus Risk within the context of the current debate on endo-
crine disrupting chemicals (EDCs) management in the EU., CHEMTRUST (Nov. 2013), http://
chemtrust.org/wp-content/uploads/Hazard-v-Risk-a-CHEM-Trust-position-paper-Nov-2013
.pdf [https://perma.cc/P2K9-UG4L]; Michael Warhurst, EU action on endocrine disruptors:
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are affected by these widespread toxins, including diabetes, bone health,
and obesity.5 This Note argues that, while classifying these chemicals is
difficult, for reasons that will be discussed, the European Union’s system
would be better off incorporating a more preventative approach with differ-
ent burdens of proof in order to err on the side of caution and regulate as
many of these harmful substances as possible.6
I. WHY ENDOCRINE DISRUPTING CHEMICALS NEED REGULATION:
INTRODUCTION TO THE ENDOCRINE SYSTEM AND ENDOCRINE
DISRUPTING CHEMICALS
The human body has extensive and physiologically complex systems
that govern particular functions necessary to sustain life.7 The endocrine
system, by way of a general summary, is a delicate system that involves
various glands and organs and governs hormone production.8 Endocrine
disrupting chemicals are a certain class of diverse and widespread chemi-
cals that are detrimental to the human body due to their effects on the
endocrine system.9 These chemicals “act via nuclear receptors, nonnuclear
steroid hormone receptors (e.g., membrane ERs), nonsteroid receptors (e.g.,
neurotransmitter receptors such as the serotonin receptor, dopamine re-
ceptor, norepinephrine receptor), orphan receptors . . . enzymatic path-
ways involved in steroid biosynthesis and/or metabolism, and numerous
other mechanisms that converge upon endocrine and reproductive sys-
tems.”10 It is clear that these chemicals can impact the body and cause
harm through a variety of pathways and physiological mechanisms.11 For
example, the type of cellular receptor is important because the receptor
type is directly linked to the kind of substance that binds to the recep-
tor.12 One class of receptors, nuclear receptors, include a type of receptor
some progress, many concerns, CHEMTRUST (Nov. 29, 2017), http://www.chemtrust.org/wp
-content/uploads/chemtrust-edcs-fresenius-nov17.pdf [https://perma.cc/4XKF-3U73].
5 Endocrine Society, supra note 2, at 1.
6 Id.
7 What is the Endocrine System?, EPA, https://www.epa.gov/endocrine-disruption/what
-endocrine-system [https://perma.cc/3QMB-35JV] (last updated Jan. 24, 2017); The
Endocrine System, HORMONE HEALTH NETWORK, https://www.hormone.org/hormones-and
-health/the-endocrine-system [https://perma.cc/QBE9-P3YY] (last visited Oct. 28, 2019).
8 HORMONE HEALTH NETWORK, supra note 7; What is the Endocrine System?, supra note 7.
9 HORMONE HEALTH NETWORK, supra note 7; What is the Endocrine System?, supra note 7.
10 Evanthia Diamanti-Kandarakis et al., Endocrine-Disrupting Chemicals: An Endocrine
Society Scientific Statement, 30 ENDOCRINE REV. 293, 294 (2009).
11 Id.
12 Stephen Tenbaum & Aria Baniahmad, Nuclear Receptors: Structure, Function and
Involvement in Disease, 29 INT’L J. BIOCHEMICAL CELL BIOLOGY 1325, 1325 (1997).
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that binds to hormones in the nucleus of a cell (intercellular) rather than
being limited to the cell membrane.13 Certain receptors do not have a cor-
responding ligand and this class is called orphan receptors.14 Because the
endocrine disruptors do not need a specific type of receptor or mechanism,
but instead can affect multiple different types including intercellular and
extracellular, they are particularly difficult to identify and regulate which,
in turn, makes them all the more dangerous.15
The endocrine disrupting chemicals are a diverse group, not just
because of how diversely they can impact the body, but also because they
are so prevalent.16 For example, these chemicals are naturally occurring
but can also be synthetic, or man-made.17 This again lends itself to the
issue of identifying the chemicals and pinpointing the harm they inflict
on public health.18 The chemicals can alter, or disrupt, the delicate balance
of the endocrine system “through environmental or inappropriate devel-
opmental exposures” and can be found in sources ranging from food to
pharmaceuticals to plastics.19 To elaborate on the previous introductory
description of the endocrine system, it is one of the human body’s main
physiological systems that functions using glands that produce hormones
that act as chemical messengers and internal regulators.20 This complex
system regulates many different physiological functions like respiration,
metabolism, movement, sexual development, and sensory perception.21 The
hormones function as chemical messages and affect the different body
systems by traveling through the bloodstream and sending chemical sig-
nals to the different tissues to direct them to perform various functions.22
The type and amount of hormone secreted by each gland can have a huge
impact on the functioning of the respective tissues.23
13 Id.
14 Id. at 1325, 1335–36.
15 See generally Thaddeus T. Schug et al., Endocrine Disrupting Chemicals and Disease
Susceptibility, 127 J. STEROID BIOCHEMICAL & MOLECULAR BIOLOGY 204, 204–15 (2011);
R. Thomas Zoeller et al., Endocrine-Disrupting Chemicals and Public Health Protection:
A Statement of Principles from The Endocrine Society, 153 ENDOCRINOLOGY 4097, 4097–
110 (2012).
16 See generally Roland Solecki et al., Scientific Principles for the Identification of Endo-
crine-Disrupting Chemicals: A Consensus Statement, 91 ARCHIVES TOXICOLOGY 1001,
1001–04 (2017).
17 Diamanti-Kandarakis et al., supra note 10, at 294.
18 See generally Solecki et al., supra note 16.
19 Diamanti-Kandarakis et al., supra note 10, at 294.
20 HORMONE HEALTH NETWORK, supra note 7; What is the Endocrine System?, supra note 7.
21 What is the Endocrine System?, supra note 7.
22 Id.
23 Id.
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The endocrine system is constantly working to maintain a delicate
balance and can be affected by many external and internal factors, in-
cluding “aging, certain diseases and conditions, stress, the environment,
and genetics.”24 This Note will focus mostly on the environmental factors
that can impact the endocrine systems, and more specifically the expo-
sure to toxins such as endocrine disrupting chemicals. The United States
Environmental Protection Agency (“EPA”) has stated that while this class
of chemicals causes effects in the wild, there is limited knowledge regard-
ing the effects of the chemicals on humans and what level of exposure
causes harm.25 This is largely due to the lack of testing done to find out the
potential of this class of chemicals to harm the body.26 The EPA acknowl-
edges that the currently employed methods are not adequate to identify
the potential risks of Endocrine Disruptors.27 It is a truly strenuous task
to identify what impacts the endocrine system because the physiological
mechanisms that govern the system are extremely intricate and complex
in addition to being incredibly sensitive to the delicate balance of internal
and external conditions.28
To further emphasize why constructing a regulatory scheme of this
nature is so difficult, this section will briefly discuss in greater detail how
the system works and different examples of disruptors. “Endocrinology is
the study of the mechanisms by which hormones coordinate and control the
functions of multiple organ systems and processes . . . .”29 A key concept
in the study of the endocrine system is the idea that hormones function and
communicate with the body via receptors, and endocrine disruptors can
impact the efficiency of those receptors.30 Sometimes the chemical disrup-
tors even prevent hormone function entirely, but the level of disruption is
hard to distinguish because the chemicals can replicate the response of the
receptors.31 The hormones act with a “lock and key” mechanism that binds
to receptors within a cell and once this binding occurs, the receptor can act
on the instructions of the chemical message which may be an alteration of
existing proteins or building new materials.32 The main producers of the
24 HORMONE HEALTH NETWORK, supra note 7.
25 See generally HORMONE HEALTH NETWORK, supra note 7; What is Endocrine Disruption?,
EPA, https://www.epa.gov/endocrine-disruption/what-endocrine-disruption [https://perma
.cc/L67P-NPF6] (last updated Feb. 22, 2017); What is the Endocrine System?, supra note 7.
26 What is the Endocrine System?, supra note 7.
27 See id.; see also EDSP Overview, supra note 3.
28 See What is Endocrine Disruption?, supra note 25.
29 Zoeller et al., supra note 15, at 4099.
30 See What is Endocrine Disruption?, supra note 25.
31 Id.
32 What is the Endocrine System?, supra note 7.
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chemical signals are the hypothalamus, which links the nervous system to
the endocrine system; the pituitary gland; the thyroid gland, which is
heavily involved in development and metabolism; the adrenal glands,
which produce stress hormones and others that respond to glucose metabo-
lism, blood pressure regulation, and salt levels in the body; the pancreas,
which regulates the sugar concentration in the blood; and the gonads,
which regulate reproduction and produce hormones like androgens, estro-
gens, and progestins.33 By way of illustrative example, the thyroid gland
makes thyroxine and triiodothyronine and these two hormones work
together to control physiological processes like growth, metabolism, and
development.34 Disruption of hormones and their receptors can have det-
rimental effects on the body; specific examples include the function and
development of the brain, reproductive system, and metabolic system.35
Endocrine disrupting chemicals are particularly dangerous because expo-
sure is widespread and subsequent harmful effects can be delayed, making
it more difficult to find correlation between the substance and the detri-
mental results of exposure.36
To qualify as an endocrine disrupting chemical, the substance must
actually physically interfere with the functioning of the endocrine sys-
tem.37 This physical interference usually occurs by disrupting the effec-
tiveness of hormone receptors, or influencing and even halting hormone
production.38 This phenomenon again implicates the issue of pinpointing
correlation, and it is for this reason that classification of the chemicals
has posed such a difficulty.39 There is a variety of ways a chemical can dis-
rupt the endocrine system.40 Sometimes the chemical mimics a hormone
that is naturally produced in the body so the body will over-respond or
under-respond.41 Other endocrine disruptors can influence the body to
respond to hormone production inappropriately.42 They can also com-
pletely block certain receptors so that the hormone does not get to trans-
mit its chemical message, and physiological processes will subsequently
33 Id.
34 Id.
35 Id.
36 Warhurst, supra note 4.
37 Robert Barouki, Endocrine Disruptors: Revisiting Concepts and Dogma in Toxicology,
340 COMPTES RENDUS BIOLOGIES 410, 411 (2017).
38 What is Endocrine Disruption?, supra note 25.
39 Id.
40 Id.
41 Id.
42 Id.
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be disrupted or prevented altogether.43 Other chemicals can interfere
with the receptors and glands that produce the hormones where the result
is an underproduction or overproduction of hormones and this interfer-
ence can, and often does, result in conditions such as hypothyroidism or
hyperthyroidism.44 Another reason the classification of these chemicals
is difficult is because the harmful impact of the chemical is measured by
“toxicity,” which is a fluid entity and can really only be estimated, rather
than quantifiably ascertained.45
For the purpose of further illustrating what an endocrine disrupt-
ing chemical is, a commonly known example is Bisphenol A, otherwise
known as BPA, widely known for its use in plastic goods.46 These sub-
stances are commonly used in everyday life and this widespread nature
is another reason why regulation is so important.47 Wide use of chemicals
like alkylphenol ethoxylates (“APEO”) is another example of how a lack
of monitoring and variety of sources contribute to harmful exposure
pathways.48 Another example provided by the EPA is diethylstilbestrol
(“DES”), which is a synthetic, or man-made, estrogen and it used to be
prescribed to pregnant women to stimulate fetal development, but it was
later discovered that the chemical caused damage in the children of the
mothers who took the drug.49 The effects of the drug included adverse
effects on the reproductive system and also was linked to vaginal cancer.50
Other chemicals that have been determined to cause adverse effects on
public health include ethane and various metabolites, polychlorinated
biphenyls, plant estrogen, and various organochlorine compounds.51
To add even further to the difficulty posed in classification and
regulation of these chemicals, it turns out that it is not just the type of
chemical that causes harm that may be hard to pinpoint but also the source
of the chemical.52 The EPA acknowledges that the chemicals may originate
43 Id.
44 See generally What is Endocrine Disruption?, supra note 25.
45 Warhurst, supra note 4.
46 See generally Angela Simonelli et al., Environmental and Occupational Exposure to
Bisphenol A and Endometriosis: Urinary and Peritoneal Fluid Concentration Levels, 90 INT’L
ARCHIVES OCCUPATIONAL & ENVTL. HEALTH 49, 50 (2017); Warhurst, supra note 4.
47 See Warhurst, supra note 4.
48 Ismail-H. Acir & Klaus Guenther, Endocrine-Disrupting Metabolites of Alkylphenol
Ethoxylates—A Critical Review of Analytical Methods, Environmental Occurrences, Toxicity,
and Regulation, 635 SCI. TOTAL ENV’T 1530, 1530–33, 1535 (2018).
49 What is Endocrine Disruption?, supra note 25.
50 Id.
51 Id.
52 See id.
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from a wide variety of sources like food, water, or the general environ-
ment.53 Because the sources are so unknown, and yet incredibly wide-
spread, the effects are unpredictable and harmful.54 This Note argues that
it is important to invest further research into identifying the link and
causation of the chemicals and the impact on health, which in turn trans-
lates to stricter regulatory methodology.55
II. THE EUROPEAN UNION AND THEIR CLASSIFICATION SYSTEM
The issue of causation and unknown impacts on public health is
what provides the basis for concern regarding the European Union’s new
regulatory scheme.56 In the past, the European Union has tried to imple-
ment many different regulations in an attempt to phase out endocrine
disruptors from numerous sources like water, other chemicals, and products
like pesticides and biocides.57 It is well-established that exposures to the
chemicals cause an immense burden from a healthcare and disease
standpoint.58 The new regulations have a low burden of proof, and so the
standard results in what amounts to an under-inclusive classification
system that could potentially cost Europe millions in repairing the damage
caused by both health repercussions and economic strain between Europe
and the countries it trades with, such as the United States.59 The United
States has attempted to suggest that the European Union use a risk-based
approach, much like the United States’ Endocrine Disruptor Screening
Program (“EDSP”) rather than the European Union’s current hazard-based
53 Id.
54 See Diamanti-Kandarakis et al., supra note 10, at 295.
55 See Almudena Veiga-Lopez et al., Obesogenic Endocrine Disrupting Chemicals: Identi-
fying Knowledge Gaps, 29 TRENDS ENDOCRINOLOGY & METABOLISM 607, 618–19 (2018).
56 See Commission Regulation 2018/605, supra note 1, at 33, 34; Defining Criteria for
Identifying Endocrine Disruptors in the Context of the Implementation of the Plant Pro-
tection Products Regulation and Biocidal Products Regulation, at 6, 15, 39, 40, COM
(2016) 350 final (June 15, 2016), https://ec.europa.eu/health/sites/health/files/endocrine
_disruptors/docs/2016_impact_assessment_en.pdf [https://perma.cc/8FGU-ZASY].
57 Latest Updates of Endocrine Disruptors Regulations and Lists in EU, CHEMSAFETYPRO,
https://www.chemsafetypro.com/Topics/EU/Endocrine_Disruptors_Regulations_and
_Lists_in_EU.html [https://perma.cc/NK8E-3LWB] (last visited Oct. 28, 2019).
58 Gregory G. Bond & Daniel R. Dietrich, Human Cost Burden of Exposure to Endocrine
Disrupting Chemicals, a Critical Review, 91 ARCHIVES TOXICOLOGY 2745, 2745–47 (2017).
59 See generally USDA, EUROPEAN COMMISSION’S PUBLIC CONSULTATION ON DEFINING
CRITERIA FOR IDENTIFYING ENDOCRINE DISRUPTORS (EDS) IN THE CONTEXT OF THE IMPLE-
MENTATION OF THE PLANT PROTECTION PRODUCT REGULATION AND BIOCIDAL PRODUCTS
REGULATION (Jan. 16, 2015), https://www.usda-eu.org/wp-content/uploads/2015/01/United
-States-Submission-Endocrine-Disrupters-2015-01-20.pdf [https://perma.cc/VFN5-Z6JB].
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approach.60 This Note will argue in favor of the type of regulatory scheme
found in the EDSP because it is a more inclusive approach and in appli-
cation it will be more preventative of more chemicals, which translates into
the minimization of environmental harm and danger to the public health.61
First, this Note will cover the European Union’s new classification system
and their reasons for adopting it, then identify issues with the system and
suggest ways to improve it based on the system used by the United States.
Since this Note will focus on the regulatory system of the European
Union, it is important to note that the European Union defines endocrine
disrupting chemicals as “exogenous substance[s] that cause[ ] adverse
health effects in an intact organism, or its progeny, secondary to changes
in endocrine function” and potential endocrine disrupting chemicals as
“substance[s] that possess[ ] properties that might be expected to lead to
endocrine disruption in an intact organism.”62 The World Health Organi-
zation has declared endocrine disrupting chemicals to be “a global threat.”63
Health complications as a result of these chemicals, including diagnostics
and treatment, have been estimated to cost Europe over 150 billion pounds
annually.64 The new regulatory scheme impacts not just Europe but the
rest of the world due to implications on international trade and agricul-
ture.65 The United States has taken measures to provide guidance and
constructive criticism, discussing the impact of inadequate regulation from
a public health perspective, but also from the international trade per-
spective where there is concern that trade could be adversely affected.66
The United States has pointed out that the key to preserving public health
is identifying and controlling products that may have adverse effects on
the endocrine system and emphasized that “measures must be developed
in accordance with scientific principles and based on the relevant scientific
evidence.”67 The United States also noted in their input to the European
Union that plant protection is vital, and “[i]mposing unnecessary restric-
tions could have far-reaching and particularly detrimental consequences.”68
60 Id. at 3–4, 14, 16.
61 Id. at 7–9.
62 Zoeller et al., supra note 15, at 4098.
63 Alyssa Alfonso, What’s More Hazardous—Endocrine Disruptors or the EU’s Proposed
Criteria?, CTR. INT’L ENVTL. L., https://www.ciel.org/endocrine-disruptors-criteria/ [https://
perma.cc/8VU3-5RZD] (last visited Oct. 28, 2019).
64 Id.
65 See USDA, supra note 59, at 3, 12–13.
66 Id. at 17.
67 Id. at 1.
68 Id.
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For example, pesticides that are employed for plant protection function
in various ways, including preventing the spread of diseases that affect
the plants and diseases that could impact humans, such as diseases that
originate from the pests themselves or carcinogens from other sources.69
Getting greater control on the exposure of the chemicals is very
important in this context because the EU is “the fifth largest export market
for U.S. agricultural products, while the United States is the largest export
market for EU agricultural products.”70 This is an important consider-
ation because the regulatory structure of the pesticides and biocides and
the control and exclusion of these products will directly impact the agri-
cultural sphere and, subsequently, the international trade between the
United States and the European Union.71 In addition, pesticide regulation
is critical, as well as biocide regulation, because pesticides are used to pro-
tect the public from diseases.72 These diseases can impact both the agricul-
tural community and the subsequent products involved in international
trade, and the chemicals may also have a direct adverse impact on human
health in the form of human-specific diseases and carcinogens.73 The ad-
ditional concern of inadequate pesticide regulation is that plants can serve
as vectors, or nonhuman carriers of disease.74 As it stands, the European
Food Safety Authority estimates that it could cost Europe more than ten
billion euros annually to both control invasive species and remedy the
damage caused.75 This cost does not even account for the cost of human
disease.76 There are other economic concerns in food production; for
example, certain food products may not be as available without the use
of pesticides, which in turn means that the agricultural yield could be
adversely affected.77 If the agricultural yield is adversely affected, it
could affect the cost of the products, and subsequently, consumer welfare;
plant-based dangers reach concerns regarding food sources, which have
69 Id.
70 Id. at 12.
71 USDA, supra note 59, at 3.
72 See generally Commission Delegated Regulation (EU) 2017/2100 of Sept. 4, 2017, Set-
ting Out Scientific Criteria for the Determination of Endocrine-Disrupting Properties
Pursuant to Regulation (EU) No. 528/212 of the European Parliament and Council, 2017
O.J. (L 301) 2, https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017
R2100&from=EN [https://perma.cc/M52D-Q52J] [hereinafter Commission Delegated
Regulation 2017/2100]; Commission Regulation 2018/605, supra note 1, at 33.
73 See Commission Delegated Regulation 2017/2100, supra note 72.
74 USDA, supra note 59, at 1–2.
75 Id. at 2.
76 Id.
77 Id. at 2–3.
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obvious implications for public health.78 Pesticide treatments work to
reduce epidemics, like the well-known Irish Potato Blight, which are a po-
tential concern in Europe seeing as a loss of crop protection could poten-
tially introduce diseases, and maybe even epidemics, back in to the modern
world.79 In addition, the Agriculture and Horticulture Development Board
has expressed their concern that “if the EU were to reject a scientific risk
based approach to regulating endocrine disruptors, the cost to UK agri-
culture alone could exceed £905 million” and in turn could impact billions
worth of imports, including United States exports.80
III. THE PROBLEM WITH THE NEW REGULATORY SYSTEM:
UNDER-INCLUSION AND OVER-EXCLUSION
On April 19, 2018, the European Union launched a new regulatory
scheme for the classification of endocrine disrupting chemicals.81 There
were supporting documents, including a guidance document developed
in part by the European Food Safety Authority and the European Chemi-
cals Agency, and a “roadmap” was published that detailed the impact as-
sessment of the regulations.82 Specifically, the guidance documents serve
the regulatory authorities on the “implementation of the scientific crite-
ria for the determination of endocrine-disrupting properties pursuant to
[the regulations].”83 The purpose of the new criteria was to ensure a “high
level of protection of both human and animal health and the environment,
in particular ensuring that substances or products placed on the market
have no harmful effect on human or animal health.”84 The European Union
stated that the point of the new criteria is to “allow [the identification of
active substances] having endocrine disrupting properties more accu-
rately.”85 The 2018 version of the EU regulation still operates by a weight
of evidence evaluation that functions by defining whether a substance
has endocrine disrupting properties if: (1) there is an adverse effect in an
78 Id. at 1, 3.
79 Id. at 2–3.
80 USDA, supra note 59, at 3.
81 Commission Regulation 2018/605, supra note 1, at 33.
82 Process to set scientific criteria to identify endocrine disruptors, EUR. COMMISSION, https://
ec.europa.eu/health/endocrine_disruptors/process_en [https://perma.cc/44PF-4DZ5] (last
visited Oct. 28, 2019).
83 Niklas Andersson et al., Guidance for the Identification of Endocrine Disruptors in the
Context of Regulations (EU) No. 528/2012 and (EC) No. 1107.2009, 16 EUR. FOOD SAFETY
AUTHORITY J. 1, 5 (2018).
84 Commission Regulation 2018/605, supra note 1, at 33.
85 Id. at 34.
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organism, (2) the mode of chemical action is via the endocrine system, and
(3) the adverse effect is causally related to the endocrine action.86 The main
issue is that the new regulations have not addressed the prior and on-
going problem with endocrine disrupting chemical classification.87 The
issue is that the burden of determining if a chemical is one from the class
of endocrine disrupting chemicals is the aforementioned weight of the
evidence approach.88 This burden of proof is too high and therefore allows
too many substances to go by unregulated.89 The hazard identification pro-
cess is not extensive, and the EU’s deficiencies are centered on data col-
lection, evaluation of the data, and the integration of the data in order
to assess the endocrine disrupting properties of various chemicals.90
In addition to the weight of the evidence approach, the new regu-
latory scheme also employs a nontarget approach in conjunction with the
weight of the evidence standard.91 The nontarget approach provides that
the effects of the chemicals will be assessed in relation to organisms of
the same taxonomic phylum.92 This approach, when practically applied,
means the effect on nontarget organisms will not be considered unless
there is special showing that it should be assessed with consideration
given to nontarget organisms.93 This approach is based on the concept
that “[o]rganisms belonging to different taxonomic phyla differ biologi-
cally on essential traits, involving different endocrine modes of action.”94
There is an additional caveat where if the intended endocrine method of
action produces the same effect on organisms of the same phylum as the
targeted one, such a method should not be considered when the intent is
to identify endocrine disruption as applied to organisms that belong to
a different taxonomic phylum.95
Requiring a special approach to show that the chemical should
even be given further consideration for analysis beyond the threshold
consideration is a high burden and results in most chemicals not being
regulated if it cannot be shown that they will have an adverse effect on
86 Melanie Gross et al., Weight of Evidence Approaches for the Identification of Endocrine
Disrupting Properties of Chemicals: Review and Recommendations for EU Regulatory
Application, 91 REG. TOXICOLOGY & PHARMACOLOGY 20, 21 (2017).
87 See id.
88 See id.
89 Warhurst, supra note 4.
90 Gross et al., supra note 86, at 21.
91 Commission Delegated Regulation 2017/2100, supra note 72, at 1–3.
92 Id. at 2.
93 See id.
94 Id.
95 Id.
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nontarget organisms, even if they very well may have an adverse effect.96
The vague nontarget evidentiary approach, combined with the equally
vague weight of the evidence approach provides a weak and under-in-
clusive regulatory scheme.97 In addition to the under-inclusivity concern,
the United States also expressed an over-inclusivity concern with the
hazard-based approach where “[s]taple agricultural products such as cof-
fee, garlic, cherries, apples, and carrots contain naturally occurring en-
docrine active substances—and could be construed as hazards.”98 This
over-inclusion is obviously a concern since these hazards are a negligible
risk as they are not inherently harmful to humans unless they are con-
sumed in massive quantities, which is unlikely.99 This is a key distinction
between a risk-based approach and a hazard-based approach.100
Based on the evidentiary defects of the regulatory scheme, more
research should be developed at the earlier stages to try and obtain a more
comprehensive understanding of the impact of the chemicals on other
organisms besides just the target species, since causation and correlation
are difficult to prove.101 This is an aspect of the program that the United
States noted in their commentary, stating “[t]he omission in the [program]
of references to scientific evidence and the relationship of that evidence
to the options is particularly striking.”102 Based on the inherent difficulty
of this task, these are inappropriate standards to determine whether a
chemical is harmful and should therefore be regulated. The key to maximiz-
ing protection from endocrine disrupting chemicals is to continually try
to understand them and how they function, so that it will be easier to not
just prevent exposure from known endocrine disruptors, but also to predict
what effects other chemicals may have that are not already classified as
endocrine disruptors. The weight of evidence and the target/nontarget
approaches are too broad and vague, and do not invest enough exploration
into determining as much as possible about the scope of the types of poten-
tially harmful chemicals and unknown impacts on public health.103 If a
chemical is suspected to be a potential endocrine disruptor, the initial re-
sponse should be to attempt to determine the response with organisms,
not just target organisms, but nontarget as well. The weight of evidence
96 See id. at 2.
97 See USDA, supra note 59, at 17.
98 Id. at 4.
99 Id.
100 Id. at 10.
101 Id. at 15.
102 Id. at 5.
103 USDA, supra note 59, at 5.
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approach was the issue with the European Union’s former regulatory
scheme and, because the new scheme still uses the same burden of proof,
the underlying issue of under-inclusion and inadequate protection from
the chemicals has yet to be addressed by the new classification scheme.104
Another criterium that gives cause for concern, for much the same
reason, is that “presumed and suspected EDCs are excluded from the
criteria,” which implicates the notion that only the “EDCs that have been
proven to have adverse effects on humans” are included in the regulatory
scheme.105 This standard of inclusion obviously excludes many unknown
hazardous chemicals and allows for these substances to go unregulated
since it limits “the scientific evidence considered.”106 Again, the result of
this overly high burden of proof is that chemicals will be excluded from
classification despite “the high likelihood they are harmful to human
health.”107 Despite the concerns that were voiced from other countries,
including the United States, during the drafting of the new regulations,
the current standard for a chemical to be considered as having endocrine
disrupting properties is if “it shows an adverse effect in [an intact organ-
ism . . .] which is a change in the morphology, physiology, growth, devel-
opment, reproduction or life span of an organism . . . that results in an
impairment of functional capacity . . . .”108 The main issue that remains
unaddressed is the “adverse effect” language. This “adverse effect” language
implies that the chemical in question needs to have already demonstrated
harmful impacts on the endocrine system.109 The criteria does not allow for
the possibility that a chemical may be harmful and so there is not any re-
search done into potential harms, since it is just assumed that if the
chemical is not known to show adverse effects then it will not be considered
in the classification system.110 This system is still based on a hazard ap-
proach, rather than a risk assessment approach, where the aforementioned
weight of the evidence approach is used to determine if a chemical is a haz-
ard or not for the purposes of classification and subsequent regulation.111
Overall, the issue with the new regulation is the hazard-based
approach, which utilizes the weight of the evidence approach rather than
a risk assessment–based approach, and uses a lower burden of proof where
104 Id. at 15–16.
105 Alfonso, supra note 63.
106 Id.
107 Id.
108 Andersson et al., supra note 83, at 7.
109 See id.
110 See id.
111 See id.
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chemicals that may have the potential to be harmful are assessed.112 These
concerns are shared with other countries, including the United States, and
public health organizations in Europe and across the globe.113 The United
States has attempted to advise the EU that their hazard based approach
would impose limitations without a solid basis of risk and would also be
lacking in evaluating potential impacts on health, which includes benefi-
cial impacts as well as adverse impacts.114 Further, the United States
pointed out that the EU’s overall plan for their regulatory scheme should
first identify the scientific evidence that serves as the basis for each classifi-
cation and provide an explanation of the evidence and methodology.115 The
United States’ report emphasizes that the EU has failed to do so, in addi-
tion to also failing to provide adequately supported impact assessments in
a way that is transparent so that the public can remain informed and easily
access the information.116 The risk assessment approach would likely
employ more resources devoted to scientific research at the initial stages
of screening the chemicals, and would therefore require a budget restruc-
turing to account for the investment.117 This Note argues that the invest-
ment would pay off in terms of increasing the general health and well-being
of the public by decreasing exposure to these toxic materials that are found
everywhere and can have dramatic effects on our bodies.
IV. THE UNITED STATES ENVIRONMENTAL PROTECTION AGENCY’S
ENDOCRINE DISRUPTOR SCREENING PROGRAM IS A BETTER
MODEL FOR CLASSIFICATION AND REGULATION
A better example of a classification scheme for the EDC’s can be
found in an EPA regulatory program, the Endocrine Disruptor Screening
Program, that is “designed to screen and test chemicals for potential endo-
crine bioactivity, and the risk of endocrine disruption in humans and
wildlife.”118 This program is designed to operate the way the critics of the
112 See id.
113 See generally USDA, supra note 59.
114 Id. at 4.
115 Id.
116 Id. at 4–6.
117 See generally Lyons, supra note 4 (providing background to the method and costs of
the risk assessment approach).
118 Natalia Garcia-Reyero & Cheryl A. Murphy, Advancing Adverse Outcome Pathways for
Risk Assessment, in A SYSTEMS BIOLOGY APPROACH TO ADVANCING ADVERSE OUTCOME PATH-
WAYS FOR RISK ASSESSMENT 5 (Natalia Garcia-Reyero & Cheryl A. Murphy eds., 2018).
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EU regulations want it to work.119 The purpose of the EDSP is to allow the
EPA to assess the risks associated with the chemicals and take subse-
quent remedial measures to address the risk.120 In 1996, the United States
Congress mandated that the EPA develop the program primarily to
identify pesticides that had detrimental effects.121 The Food Quality Pro-
tection Act states that the EPA needs to make safety finding of “reason-
able certainty that no harm” would come from an “aggregate exposure” to
the chemicals.122 The EPA regulates the chemicals utilizing a risk-based
approach, and one of these methodologies is the Endocrine Disruptor
Screening Program.123 The EDSP is an intensive screening process that
assesses potential risks of chemicals, and uses an “Adverse Outcome
Pathway (“AOP”) framework” that focuses on the toxicity pathways of
potential toxins and to assess them, uses linkages of biologically likely
mechanistic relationships to show biological pathways or emphasize a
lack of understanding of certain pathways.124 In more concise terms, the
proper regulation requires “hazard identification, hazard characteriza-
tion, exposure assessment, and risk characterization.”125 This approach
is based on the general distinction between the risk-based and hazard-
based approaches.126 The EU’s regulatory scheme uses the first two cri-
teria, while the U.S. regulations use all four steps of risk analysis.127 The
EDSP has three stages of implementation: prioritization, screening, and
testing.128 The screening process is described in further detail below, as well
as deficiencies in the system.
The United States’ risk assessment approach consists of a two-
tiered screening process where the first phase screens chemicals to test
for potential interactions, adverse or otherwise, with the endocrine sys-
tem.129 Tier 1 screening data is the threshold for determining a chemical’s
119 Id. at 16.
120 National Archives and Records Administration, Endocrine Disruptor Screening Program,
Policies and Procedures for Initial Screening, 74 Fed. Reg. 17,560, 17,561 (Apr. 15, 2009),
https://www.regulations.gov/document?D=EPA-HQ-OPPT-2007-1080-0029 [https://perma
.cc/G8HE-N7WF].
121 USDA, supra note 59, at 7.
122 Id.
123 Id.
124 Id. at 7–9.
125 Id at 7.
126 Lyons, supra note 4.
127 USDA, supra note 59, at 7.
128 Id. at 8–9.
129 Id. at 7–8.
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potential to interact with the endocrine system.130 This phase requires the
development of a chemical screening program where the testing used is
appropriately validated and the results are meant to indicate the presence
of hormonal effects.131 The specific systems that are examined include the
thyroid, estrogen, and androgen hormone systems.132 If a chemical is found
to show potential interaction, the chemical is moved to the second phase.133
The second phase consists of looking further into the interactions, deter-
mining exactly what kind of interaction occurs, and what dose or amount
of the chemical constitutes the threshold amount to cause the interac-
tion.134 The Tier 2 testing phase also sets out a qualitative correlation
between the dose, or amount, of the chemical and the resulting adverse
effect.135 This information is combined with information regarding expo-
sure and this produces a risk assessment to support mitigation measures
and subsequent regulatory decisions.136 Specifically, this information is
used to assess if a certain chemical or other substance found in sources
accessible to humans, like sources of drinking water, poses a risk to the en-
vironment and public health.137 This kind of method employs high through-
put assays that allow for a variety of chemicals to be efficiently evaluated
for bioactivity and biochemical interactions with the chemicals.138 In
addition, there are advanced computational methods used to measure
130 Endocrine Disruptor Screening Program Tier 1 Assessments, EPA, https://www.epa.gov
/ingredients-used-pesticide-products/endocrine-disruptor-screening-program-tier-1-as
sessments [https://perma.cc/TE79-YLRC] (last updated June 14, 2017).
131 Endocrine Disruptor Screening Program; Final Second List of Chemicals and Sub-
stances for Tier 1 Screening, 78 Fed. Reg. 35,922, 35,922 (June 14, 2013), https://www.fed
eralregister.gov/documents/2013/06/14/2013-14232/endocrine-disruptor-screening-pro
gram-final-second-list-of-chemicals-and-substances-for-tier-1 [https://perma.cc/YPP9-SDGA].
132 Id.
133 Id.
134 USDA, supra note 59, at 8.
135 See generally EDSP Overview, supra note 3; Endocrine Disruptor Screening Program
(EDSP) Universe of Chemicals, EPA, https://www.epa.gov/endocrine-disruption/endocrine-dis
ruptor-screening-program-edsp-universe-chemicals [https://perma.cc/53QV-LDBY] (last up-
dated Feb. 22, 2017) [hereinafter EDSP Universe of Chemicals] (providing background
information about Tier 2 testing related to the EDSP and Risk Assessment Approach).
136 See generally EDSP Overview, supra note 3; EDSP Universe of Chemicals, supra note 135.
137 How Does EPA Use Information from the Endocrine Disruptor Screening Program?, EPA,
https://www.epa.gov/endocrine-disruption/how-does-epa-use-information-endocrine-dis
ruptor-screening-program [https://perma.cc/FKX8-WN3X] (last updated Aug. 30, 2016).
138 Use of High Throughput Assays and Computational Tools in the Endocrine Disruptor
Screening Program, EPA, https://www.epa.gov/endocrine-disruption/use-high-throughput
-assays-and-computational-tools-endocrine-disruptor [https://perma.cc/YP3N-5K9U] (last
updated Feb. 22, 2017).
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bioactivity.139 The computational modeling, combined with molecular bi-
ology, is used with in vitro methodologies that allow for detection of
endocrine-specific events and pathways, an entire process that helps pri-
oritize the information found in the Tier 1 phase of the research.140
While the EDSP is a more preventative approach, it is not without
its deficiencies.141 Firstly, the program sometimes fails to validate the
Tier 1 and Tier 2 testing, which is an issue because the process of valida-
tion is what determines if the information is reliable.142 Secondly, some
of the Tier 1 tests often result in false positives where the results say the
endocrine system is impacted when it may not actually affect it at all.143
However, even though the methodology is not perfect, the EPA has made
efforts over the recent years to reevaluate it and now employs new com-
putational methods to estimate the risk to humans and the environment.144
Specifically, “pathway frameworks may be used to evaluate the predictive
performance of one or more computational models to predict downstream
key events.”145 These computational approaches may be able to serve as
an alternative to the typical Tier 1 screening approach at some point.146
This kind of proactive, research-heavy, and focused approach is what the
current EU criteria is missing, and this kind of approach would address the
widespread critique of the overly high burden of proof and over-exclusion
of potential toxins while improving detection and identification of endo-
crine disrupting chemicals.147
CONCLUSION
The endocrine system is a complex and delicate physiological
network that is easily corrupted by both internal and external factors,
139 Id.
140 EDSP in the 21st Century, supra note 3.
141 The EPA’s Endocrine Disruptor Screening Program, PETA, https://www.peta.org/is
sues/animals-used-for-experimentation/epa-edsp/ [https://perma.cc/GKN6-25ME] (last
visited Oct. 28, 2019).
142 Id.
143 Id.
144 Id.
145 Patience Browne et al., Use of High-Throughput and Computational Approaches for
Endocrine Pathway Screening, in A SYSTEMS BIOLOGY APPROACH TO ADVANCING ADVERSE
OUTCOME PATHWAYS FOR RISK ASSESSMENT 15 (Natalia Garcia-Reyero & Cheryl A.
Murphy eds., 2018).
146 Id.
147 See generally USDA, supra note 59, at 17 (providing background information as to why
the United States follows a risk-based approach and why the EU does not).
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including toxins like endocrine disrupting chemicals which are both natu-
rally occurring and synthetic, and can originate from a variety of sources.148
Because of the complexity of the interactions within the endocrine system,
it is difficult to pinpoint exactly what chemicals harm the endocrine sys-
tem, and even once a toxin is identified, it is difficult to measure the scope
of the impact or confirm causation.149 There is additional complexity given
that there is often a disconnect between the scientific research and meth-
odology used in policy implementation.150
The EU’s new regulatory scheme is a hazard-based approach that
does not provide enough specificity and will continue to allow too many
potential toxic chemicals to go unregulated, or will over-regulate chemical
sources that are not a real concern. The United States’ Endocrine Dis-
ruptor Screening Program, overseen by the EPA, is a more inclusive and
preventative approach that provides for a more comprehensive level of
protection and screening that utilizes the same initial approach as the
EU, but adds several additional steps to further assess risk.151 The EU
should incorporate aspects of this program into its own regulatory scheme,
with emphasis on an elevated burden of proof, as opposed to the current
“weight of the evidence” standard. The elevated burden of proof will place
the focus on more preventative screening, which in turn will ensure more
chemicals will be regulated and exposure to harm will be minimized.
This minimization will cut the cost of medical expenses, prevent disease,
preserve the agricultural markets, and will further protect the health of
international trade. The EU should revise their regulatory scheme of en-
docrine disrupting chemicals, and look to the EPA’s Endocrine Disruptor
Screening Program for guidance. A regulatory scheme for substances such
as these chemicals, that are difficult to identify and trace, should have
a more prevention-based focus so as to avoid any under-inclusion and
overly harmful exposure.
148 For further explanation, see supra Part I.
149 Id.
150 Marlene Agerstrand et al., An Academic Researcher’s Guide to Increased Impact on
Regulatory Assessment of Chemicals, 19 ENVTL. SCI.: PROCESSES & IMPACTS 645, 651 (2017).
151 See generally USDA, supra note 59, at 7–8 (providing additional support for why the
EDSP might be more comprehensive and successful than the EU’s approach).
